BRIEF-Pfizer And Biontech Receive Expanded U.S. FDA Emergency Use Authorization Of Covid-19 Vaccine Booster To Include Individuals 18 And Older


Reuters | Updated: 19-11-2021 19:27 IST | Created: 19-11-2021 19:27 IST
BRIEF-Pfizer And Biontech Receive Expanded U.S. FDA Emergency Use Authorization Of Covid-19 Vaccine Booster To Include Individuals 18 And Older

Nov 19 (Reuters) -

* PFIZER AND BIONTECH RECEIVE EXPANDED U.S. FDA EMERGENCY USE AUTHORIZATION OF COVID-19 VACCINE BOOSTER TO INCLUDE INDIVIDUALS 18 AND OLDER Source text for Eikon: Further company coverage: [ ]

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback